tirzepatide phase 3 mash Incretin-based therapy for MASH: are two better than one? Competition in MASH Is Heating

ROS accumulate, damaging membranes, enzymes, and DNA

For my patients with serious health challenges, this isnt a wellness trend

Nat Med 15:629632 Singh S, Padovani D, Leslie RA, Chiku T, Banerjee R (2009) Relative contributions of cystathionine beta-synthase and gamma-cystathionase to H 2 S biogenesis via alternative trans-sulfuration reactions

GIM MC CHOLESTEROL & TRIGLYCERIDE To xon c th gip h thp mc Cholesterol LDL v tng mc Cholesterol HDL trong tng lng Cholesterol ca c th

The future of these medications probably involves optimizing the right receptor targets for the right patient - personalized weight loss medicine optimized for individual effectiveness and tolerability

If GI side effects are manageable, add cagrilintide at 0.25 mg weekly starting in week 5, while simultaneously increasing retatrutide to 2 mg as per its standard titration